Medical News: ASCO: Pemetrexed Delays Lung Cancer Progression - in Meeting Coverage, ASCO from MedPage Today
Links shared publicly online about this topic.
- 228total visits
Medical News: ASCO: Pemetrexed Delays Lung Cancer Progression - in Meeting Coverage, ASCO from MedPage Today
View full resource at medpagetoday.com
Tags: Cancer, Lung Cancer, Non-Small Cell Lung Cancer Medication, Lung, Alimta, News, Medical
Most Recently Shared on June 10, 2011 at 5:42 pm By:
ASCO: Pemetrexed Delays Lung Cancer Progression http://bit.ly/jYdsrc
Medical News: ASCO: Pemetrexed Delays Lung Cancer Progression - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Maintenance therapy with pemetrexed (Alimta) appears to significantly extend progression-free survival in advanced lung cancer patients, although the difference when compared with placebo i” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 7:32 pm By:
Roger D. Jones, PhD Health Executive, Health Social Media, PhD, and Doctor
Medical News: ASCO: Pemetrexed Delays Lung Cancer Progression - http://t.co/cjnrzrg from @medpagetoday #health #medicine
Medical News: ASCO: Pemetrexed Delays Lung Cancer Progression - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “CHICAGO -- Maintenance therapy with pemetrexed (Alimta) appears to significantly extend progression-free survival in advanced lung cancer patients, although the difference when compared with placebo i” View full resource at medpagetoday.com
Most Recently Shared on June 10, 2011 at 6:03 pm By:
ASCO: Pemetrexed Delays Lung Cancer Progression http://bit.ly/irkEQt
Medical News: ASCO: Maintenance Pemetrexed Extends NSCLC Survival by Three Months - in Meeting Coverage, ASCO from MedPage Today
medpagetoday.com — “ORLANDO -- Maintenance therapy with pemetrexed (Alimta) added about three months to overall survival in patients with advanced, non-small cell lung cancer (NSCLC) who had not progressed on platinum-ba” View full resource at medpagetoday.com
Most Recently Shared on May 30, 2009 at 3:57 pm By:
ASCO: Maintenance Pemetrexed Extends NSCLC Survival by Three Months http://tinyurl.com/nojom4
Advertisement
